Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice

[1]  Min Kyung Sung,et al.  A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[2]  I. Lossos,et al.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.

[3]  O. Nureki,et al.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[4]  C. Hother,et al.  Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma , 2013, Haematologica.

[5]  K. Tarte,et al.  ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma , 2013, PloS one.

[6]  Edita Kriukienė,et al.  5-Hydroxymethylcytosine--the elusive epigenetic mark in mammalian DNA. , 2012, Chemical Society reviews.

[7]  A. Iwama,et al.  TET2 is essential for survival and hematopoietic stem cell homeostasis , 2012, Leukemia.

[8]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[9]  P. Gaulard,et al.  Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. , 2012, Blood.

[10]  Juan F. García,et al.  Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice. , 2012, Blood.

[11]  Zhiyong Guo,et al.  The development and function of follicular helper T cells in immune responses , 2012, Cellular and Molecular Immunology.

[12]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[13]  S. Crotty,et al.  Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation , 2012, The Journal of Immunology.

[14]  Y. Ikeda,et al.  Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells , 2012, Scientific Reports.

[15]  J. Cigudosa,et al.  TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia , 2012, PloS one.

[16]  W. Reik,et al.  Uncovering the role of 5-hydroxymethylcytosine in the epigenome , 2011, Nature Reviews Genetics.

[17]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[18]  K. Rajewsky,et al.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.

[19]  P. Gaulard,et al.  Follicular helper T cells: implications in neoplastic hematopathology. , 2011, Seminars in diagnostic pathology.

[20]  A. Klungland,et al.  The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. , 2011, Biochemical and biophysical research communications.

[21]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[22]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[23]  Philipp Kapranov,et al.  Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.

[24]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[25]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[26]  L. Aravind,et al.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.

[27]  Ruchir R. Shah,et al.  DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas , 2010, The Journal of experimental medicine.

[28]  Yi Zhang,et al.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.

[29]  N. Watanabe,et al.  c‐Maf activates the promoter and enhancer of the IL‐21 gene, and TGF‐β inhibits c‐Maf‐induced IL‐21 production in CD4+ T cells , 2010, Journal of leukocyte biology.

[30]  P. Gaulard,et al.  Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma , 2010, British journal of haematology.

[31]  J. Soulier,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[32]  C. Mackay,et al.  The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. , 2009, Immunity.

[33]  Andrew H. Beck,et al.  Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. , 2009, American journal of clinical pathology.

[34]  R. Nurieva,et al.  Bcl6 Mediates the Development of T Follicular Helper Cells , 2009, Science.

[35]  D. Gilliland,et al.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.

[36]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[37]  Jungwon Huh,et al.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. , 2009, Blood.

[38]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[39]  N. Fazilleau,et al.  Follicular helper T cells: lineage and location. , 2009, Immunity.

[40]  Valeria Santini,et al.  Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. , 2009, The Lancet. Oncology.

[41]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[42]  K. Yamamura,et al.  Characterization of Ayu17-449 gene expression and resultant kidney pathology in a knockout mouse model , 2008, Transgenic Research.

[43]  Christian Gisselbrecht,et al.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.

[44]  Diego G. Silva,et al.  Identification of T Cell-Restricted Genes, and Signatures for Different T Cell Responses, Using a Comprehensive Collection of Microarray Datasets1 , 2005, The Journal of Immunology.

[45]  C. Mackay,et al.  Follicular B helper T cells in antibody responses and autoimmunity , 2005, Nature Reviews Immunology.

[46]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[48]  D. Felsher,et al.  The human BCL6 transgene promotes the development of lymphomas in the mouse. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Mackay,et al.  T Follicular Helper Cells Express a Distinctive Transcriptional Profile, Reflecting Their Role as Non-Th1/Th2 Effector Cells That Provide Help for B Cells1 , 2004, The Journal of Immunology.

[50]  F. Alt,et al.  Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. , 1999, Immunity.

[51]  M. Kikuchi,et al.  Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. , 1999, Human pathology.

[52]  M. Kanehisa,et al.  Computation with the KEGG pathway database. , 1998, Bio Systems.

[53]  T. Tollefsbol,et al.  DNA methylation detection: bisulfite genomic sequencing analysis. , 2011, Methods in molecular biology.

[54]  J. Issa,et al.  Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. , 2007, Blood.